Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

Not Applicable

Completed

• Conditions: Smoking
• Interventions: Behavioral: ACT; Behavioral: CBT

• Registration Number: NCT01812278
• Lead Sponsor: Fred Hutchinson Cancer Center

Brief Summary

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-03-14
• Study First Submitted QC: 2013-03-14
• Study First Posted: 2013-03-18
• Study Start: 2014-03-24
• Primary Completion: 2016-10-26
• Status Verified: 2019-12
• Study Completion: 2019-12-31
• Last Update Submitted: 2020-07-29
• Last Update Posted: 2020-07-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2637

Inclusion Criteria

• age 18 or older
• smokes at least five cigarettes daily for at least past 12 months
• wants to quit in next 30 days
• willing to be randomly assigned to either group
• resides in US
• has at least weekly access to a high speed Internet connection and email
• willing and able to read in English
• not participating in other smoking cessation interventions (including our other intervention studies
• has never used the Smokefree.gov website
• willing to complete all three follow-up surveys
• provide email, phone, and mailing address
• provide contact information for two collaterals (e.g., relatives).
• does not have family, friends, or other household members participating

Exclusion Criteria

• The exclusion criteria are the opposite of the inclusion criteria above.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
ACT	ACT	Acceptance \& Commitment Therapy
CBT	CBT	Cognitive Behavioral Therapy

Primary Outcome Measures

Name	Time	Method
30-day point prevalence abstinence	12 month post randomization	No smoking in the past 30 days, as reported 12 month post treatment.

Secondary Outcome Measures

Name	Time	Method
7-day, 24-hour, and 30-day point prevalence quit rates	3 months, 6 months, and 12 months post treatment	12 months: 24-hour and 7-day point prevalence quit rates. 3 and 6 months: 24-hour, 7-day, and 30-day point prevalence quit rates. Across 3, 6, and 12 month timepoints, the repeated 30-day point prevalence abstinence.

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center; 🇺🇸 Seattle, Washington, United States